Correlation Between BB Biotech and Lyxor UCITS

Can any of the company-specific risk be diversified away by investing in both BB Biotech and Lyxor UCITS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Lyxor UCITS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BB Biotech AG and Lyxor UCITS Stoxx, you can compare the effects of market volatilities on BB Biotech and Lyxor UCITS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Lyxor UCITS. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Lyxor UCITS.

Diversification Opportunities for BB Biotech and Lyxor UCITS

-0.34

Correlation Coefficient

BB Biotech  Lyxor UCITS

Very good diversification

The 3 months correlation between BION and Lyxor is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Lyxor UCITS Stoxx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyxor UCITS Stoxx and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Lyxor UCITS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyxor UCITS Stoxx has no effect on the direction of BB Biotech i.e., BB Biotech and Lyxor UCITS go up and down completely randomly.

Pair Corralation between BB Biotech and Lyxor UCITS

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the Lyxor UCITS. In addition to that, BB Biotech is 1.47 times more volatile than Lyxor UCITS Stoxx. It trades about 0.0 of its total potential returns per unit of risk. Lyxor UCITS Stoxx is currently generating about 0.03 per unit of volatility. If you would invest  5,295  in Lyxor UCITS Stoxx on September 20, 2024 and sell it today you would earn a total of  70.00  from holding Lyxor UCITS Stoxx or generate 1.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BB Biotech AG  vs.  Lyxor UCITS Stoxx

BB Biotech AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Lyxor UCITS Stoxx

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lyxor UCITS Stoxx are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable technical and fundamental indicators, Lyxor UCITS is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with BB Biotech and Lyxor UCITS

The main advantage of trading using opposite BB Biotech and Lyxor UCITS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Lyxor UCITS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyxor UCITS will offset losses from the drop in Lyxor UCITS's long position.

The idea behind BB Biotech AG and Lyxor UCITS Stoxx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.